Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening
Shani Paluch–Shimon(Hebrew University of Jerusalem), Elżbieta Senkus(Gdańsk Medical University), Maria João Cardoso(Champalimaud Foundation), Fátima Cardoso(Breast Cancer Alliance), Fiona J. Gilbert(University of Cambridge), Judith Balmañà(Vall d'Hebron Hospital Universitari), Cristiana Sessa(Institute of Oncology Research)
Cited by 404
Related Papers
International evaluation of an AI system for breast cancer screening
|Nature|2020|3.1k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k